CogniVue Corporation
community-based medical facility which she established in 1996 for the purpose of enhancing diagnosis and treatment for individuals with Alzheimer’s disease and related disorders. Her memory clinic and dementia research site are among the most active in Canada.
Dr. Cohen has over 28 years of experience in clinical research and has been a site PI for over 180 pharmacological trials. She represents Canada on international advisory boards and steering committees and is a consultant to a wide range of stakeholders including government organizations and patient advocacy groups. She is a frequent lecturer and contributes to media events including those on medical ethics. She is known for her advocacy of individuals with neurodegenerative diseases.
This person is not in the org chart
This person is not in any offices
CogniVue Corporation
Cognivue is the world's first FDA-cleared computerized test of cognitive function. It adapts to the visual and mobile ability of the user and provides a personalized, consistent, reliable self-assessment of your cognitive and overall brain health.